Clinical Trials Logo

Clinical Trial Summary

In earlier studies, it was found that patients of Wilson disease with new diagnosed who only has neurological symptoms often had DWI hyper-intensity in brain MRI, which was more common in putamen and midbrain, indicating that the disease was in the acute stage. However, many patients had ADC hyper-intensity or hypo-intensity at the same time, and the two different signals represented different disease processes from an imaging perspective. The former indicating T2 penetration effect, and the latter represents diffusion limitation, which indicating the presence of local inflammation, edema, etc. Whether the signal changes of these two different matching modes have guiding significance for the early de-copper treatment for WD, one is the core point of our study. We hope to exploring the predictive value about DWI-ACD signal matching for symptoms changes in the earlier time of de-copper treatment through this study.


Clinical Trial Description

n/a


Study Design


NCT number NCT06196931
Study type Observational
Source Hospital Affiliated to the Institute of Neurology, Anhui University of Chinese Medicine
Contact
Status Not yet recruiting
Phase
Start date January 1, 2024
Completion date December 31, 2026